Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab
Crossref DOI link: https://doi.org/10.1007/s10620-015-3581-4
Published Online: 2015-02-12
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Steenholdt, Casper
Brynskov, Jørn
Thomsen, Ole Ø.
Munck, Lars K.
Fallingborg, Jan
Christensen, Lisbet A.
Pedersen, Gitte
Kjeldsen, Jens
Jacobsen, Bent A.
Oxholm, Anne Sophie
Kjellberg, Jakob
Bendtzen, Klaus
Ainsworth, Mark A.
Text and Data Mining valid from 2015-02-12